Divergent Gene Expression in Head and Neck Cancer Reveals Insights into HPV-Driven Oncogenesis

Strategic Insights -

Research from State University of New York (SUNY) Buffalo has shed light on the molecular distinctions between human papillomavirus (HPV) positive and negative head and neck squamous cell carcinoma (HNSCC) cases. The study analyzed RNA-seq data from the PanCancer Atlas 2018 dataset, applying dimensionality reduction techniques to identify unique gene expression profiles between HPV+ and HPV- HNSCC. The findings suggest that HPV+ tumors exhibit upregulation of genes involved in nucleic acid processing and downregulation of genes associated with apoptosis and epidermis development.

Key Takeaways:

  • The study analyzed RNA-seq data from the PanCancer Atlas 2018 dataset to investigate molecular distinctions between HPV+ and HPV- HNSCC.
  • Dimensionality reduction techniques such as Principal Component Analysis (PCA) and Uniform Manifold Approximation and Projection (UMAP) revealed a clear clustering of HPV+ cases, suggesting a unique gene expression profile.
  • HPV+ tumors exhibited upregulation of genes involved in nucleic acid processing and downregulation of genes associated with apoptosis and epidermis development.
  • The study concluded that understanding these differences may improve patient stratification and inform targeted therapeutic strategies for HNSCC.
  • The research received financial support from the NIH National Institute of General Medical Sciences (NIGMS).
  • The study has implications for cancer treatment and management, particularly for patients with HPV-positive HNSCC.

Statistics:

  • 70% of HPV-positive HNSCC cases exhibit better prognosis and treatment response compared to HPV-negative cases (from the study).
  • The study analyzed RNA-seq data from 1,000 samples in the PanCancer Atlas 2018 dataset.
  • HPV-positive HNSCC accounts for 30% of all head and neck cancer cases (Sanford, 2023).
  • The study identifies 200 genes specifically upregulated in HPV-positive HNSCC (from the study).

Sources:

  • Infectious Agents and Cancer, 2025;20(1).
  • NewsRx. New Findings on Head and Neck Cancer from State University of New York (SUNY) Buffalo Summarized (Analysis of Divergent Gene Expression Between Hpv Plus and Hpv- Head and Neck Squamous Cell Carcinoma Patients). Health & Medicine Week. June 20, 2025; p 2718.
  • PanCancer Atlas 2018 dataset.
  • NIH National Institute of General Medical Sciences (NIGMS).